Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 06/23/2025 3:20:56 PM
Board Marks: 278
Posts Today: 0
Board Views Today: 5580
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
49203
I do think Leo is doing the right thing
zdubble17
09/24/2018 10:08:40 AM
49202
This is the reason investors need to block the
(1)
NickAidenNY
09/24/2018 10:08:25 AM
49201
re another stock: "...a host of angry short
(1)
Drano
09/24/2018 10:04:38 AM
49200
How many insurance companies are going to pay for
(3)
Drano
09/24/2018 9:38:30 AM
49199
That's why we have the tag team last night and
(4)
Drano
09/24/2018 9:36:48 AM
49198
Funny this fluff business. I have not been able
(1)
RusticBum
09/24/2018 9:35:48 AM
49197
Well they do, BP needs to make sure that their
(3)
zdubble17
09/24/2018 9:35:44 AM
49196
Over the last 5 years my two largest holdings:
(1)
NickAidenNY
09/24/2018 9:27:04 AM
49195
That PR tells me that Leo is extremely confident
(2)
smokenhot
09/24/2018 9:23:56 AM
49194
Love the management comments and sure sounds like
(2)
AlanC
09/24/2018 9:22:45 AM
49193
Funny that the multi ID's talk about trial
(3)
Kelt
09/24/2018 9:14:20 AM
49192
Thanks. My youth came flashing back; the times
(1)
RusticBum
09/24/2018 8:54:31 AM
49191
Looking forward to see what October
bejamin
09/24/2018 8:48:14 AM
49190
Where did I say that IV drug works better? As
(1)
RusticBum
09/24/2018 8:47:52 AM
49189
Not a real big fan of this PR. If there is a
(2)
bejamin
09/24/2018 8:47:24 AM
49188
Excellent article showing why B-OM the leader of
(2)
petemantx
09/24/2018 8:37:30 AM
49187
What concern would a BP have with what IPIX is
(1)
petemantx
09/24/2018 8:29:11 AM
49186
Alan saw your post after I posted. Nice to see!
4kids
09/24/2018 8:11:45 AM
49185
News alert per Fidelity. Traveling so maybe
4kids
09/24/2018 8:04:19 AM
49184
Innovation Pharmaceuticals Provides a Comparative
(1)
AlanC
09/24/2018 7:43:26 AM
49183
If Leo doesn't have a deal done in October and
bejamin
09/24/2018 7:37:11 AM
49182
To finish, I think were buying time till 1st
(3)
Trading Pro Broker
09/24/2018 7:36:05 AM
49181
Good reminder to folks on the value of B-OM. A
Trading Pro Broker
09/24/2018 7:33:06 AM
49180
Very good discussion you started, like to see
bejamin
09/24/2018 7:31:39 AM
49179
https://mailchi.mp/ipharminc/innovation-pharmaceu
(1)
Commando911
09/24/2018 7:23:44 AM
49178
I know I'm not a fan of those who attempt to
(1)
BooDog
09/24/2018 7:23:39 AM
49177
and a PR on OM
smokenhot
09/24/2018 7:16:38 AM
49176
New B-OM comparison Blog
(2)
smokenhot
09/24/2018 7:02:28 AM
49175
IMO A big Pharma is doing due diligence and found
zdubble17
09/23/2018 11:08:54 PM
49174
I agree...but Im not concerned. If money were
Commando911
09/23/2018 10:25:10 PM
49173
No, it's not medical semantics. You're making a
(5)
Drano
09/23/2018 8:35:45 PM
49172
I think I love you!!! Kelt
Kelt
09/23/2018 8:33:16 PM
49171
Seemingly contrary. Over differences are over
(1)
RusticBum
09/23/2018 8:19:10 PM
49170
Nothing strange at all about not paying someone
(2)
Drano
09/23/2018 7:52:35 PM
49169
No, the board is not "alarmingly paranoid."
(5)
Drano
09/23/2018 7:50:29 PM
49168
The timing just seems weird to me. IPIX is close
smokenhot
09/23/2018 7:37:17 PM
49167
What makes you think that lesions show up fully
(2)
RusticBum
09/23/2018 5:27:56 PM
49166
My bet is you get to stock the Scotch, maybe
incubus
09/23/2018 5:14:05 PM
49165
Please don't let facts get in the way of your
(4)
Drano
09/23/2018 4:37:48 PM
49164
As you said Brilacidin does not have systemic
(2)
RusticBum
09/23/2018 4:17:29 PM
49163
Well here we are folks at the last trading week
(12)
Kelt
09/23/2018 1:42:25 PM
49162
Ahhh Yes. A little word twisting here,a little
(2)
Kelt
09/23/2018 1:40:12 PM
49161
Menon is in his mid-70's and was already on half
Drano
09/23/2018 1:36:55 PM
49160
Is it possible that Menon's termination has
smokenhot
09/23/2018 1:18:21 PM
49159
We have only people's word for it that they are
(2)
Drano
09/23/2018 12:58:15 PM
49158
That is incorrect. Bril-OM PREVENTS lesions from
(6)
Drano
09/23/2018 12:40:39 PM
49157
If both Galera's GC4419 and Brilacidin get
(1)
RusticBum
09/23/2018 11:57:00 AM
49156
Accusing long term investors of being short multi
(2)
bejamin
09/23/2018 11:42:25 AM
49155
It's always good to have more than one treatment
(3)
Drano
09/22/2018 3:41:30 PM
49154
Could be a second line treatment after B-OM was
Trading Pro Broker
09/22/2018 3:36:35 PM
Newer
Older
Recent Articles
Union Bankshares Reports Strong Growth and Dividend Announcement
Transforming Tobacco: 22nd Century's Lower Nicotine Innovations
Royalty Pharma's Upcoming Q2 2025 Financial Announcement
Exploring N-able Inc's P/E Ratio and Investment Insights
Brian Saucier Takes Charge as Director of Engineering at RK Logistics
Art and Agriculture Unite to Combat Food Insecurity Efforts
Venterra Realty Unveils The Delta Pearland Apartments
Saks Global Welcomes Brandy Richardson as New CFO Executive
Audien Hearing Strengthens Leadership and Launches New Initiative
Dakota Secures $12.5M Investment to Transform Business Banking
Revolutionizing Data Centers: The Future of Standby Generators
BAY Miner Unveils Revolutionary Free Mining Mobile App
AWG Crypto Unveils Innovative 1-Day XRP Mining Contract Today
Anticipating Ashland's Earnings: What to Expect This Quarter
Disney's CEO to Honor Disneyland's 70th with NYSE Bell Ringing
Mach Industries Enhances Government Relations Team for Innovation
Transforming Leadership at the National Kidney Foundation
Flexible Solutions Reports Impressive Q2 Revenue Growth
NR7 Miner Launches XRP Cloud Mining for Stable Earnings
Costco Declares Significant Cash Dividend for Investors
Understanding Hims & Hers Health’s Ongoing Class Action Suit
Badger Infrastructure Solutions Set to Announce Q2 Results Soon
The Incredible Growth of Carpenter Technology Over 15 Years
Analyzing Short Interest Trends in Laureate Education Inc
Analyzing Short Interest Trends for Arthur J. Gallagher Stock
Analyzing Warrior Met Coal's Increasing Short Interest Trends
Earnings Insights: Strategic Picks for Upcoming Reports
First Industrial Realty Trust Sees Strong Growth in Q2
Grants to Promote Heritage Tourism and Local Development
Investing in Guidewire Software: 10-Year Growth Journey
Potomac Bancshares Announces Quarterly Cash Dividend Details
Marvell Technology's Stock Price Dynamics Explained This Week
Chord Energy Announces Earnings Call for Q2 2025 Results
U.S. Initiative for Nuclear Fuel Supply Boosts Energy Fuels Inc
Chesapeake Utilities to Host Q2 Earnings Call on August 8, 2025
Vornado Realty Trust Secures $450 Million Refinancing Deal
I.M.P. Launches Unique Frites Stand at The Wharf Experience
Greif, Inc. Embarks on Sustainable Energy Initiative in Europe
TriggerTech Enhances Precision Through Hawkins Precision Deal
Exploring Analog Devices: A $1000 Investment Journey
Teladoc Health's Upcoming Q2 2025 Results and Insights
Vishay Precision Group's Q2 Fiscal 2025 Earnings Call Insights
United Airlines Reports Q2 Results: Revenue Miss, EPS Beat
Ahold Delhaize Data Breach: What Employees Need to Know
Rocket Pharmaceuticals Faces Legal Actions for Securities Fraud
W.W. Grainger's Impressive Stock Growth Over the Past Five Years
Analyzing Enphase Energy's Performance and Market Outlook
Understanding Recent Bullish Trends with GE Vernova (GEV)
A Comprehensive Look at Nike's Options Trading Patterns
Cigna Group: Understanding Market Trends Through Options Analysis